Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Salvage lopinavir-ritonavir therapy in human immunodeficiency virus-infected children.

The Pediatric infectious disease journal - 1 Oct 2004

Resino Salvador, Bellón José Maria, Ramos José Tomás, Navarro Maria Luisa, Martín-Fontelos Pablo, Cabrero Esther, Muñoz-Fernández Maria Angeles

Abstract excerpt

OBJECTIVE: To study the control of viral replication in human immunodeficiency virus (HIV)-infected children on different salvage therapies. DESIGN AND SETTING: A retrospective observational study in 120 HIV-infected children was conducted. The children were divided into 3 groups according to their salvage therapies: (1) children receiving first line highly active antiretroviral therapy (HAART); (2) protease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Genes, Viral

Share to Lopinavir

Share to Pyrimidinones

Share to Ritonavir

Share to Salvage Therapy

Source

Identifiers

PMID: 15602192
DOI: 10.1097/01.inf.0000142170.52155.7f

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Salvage lopinavir-ritonavir therapy in human immunodeficiency virus-infected children.PMID 15602192Read ↗

Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure.Semantic proximity Read ↗

Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014.Semantic proximity Read ↗

Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy.Semantic proximity Read ↗

Predictive factors of virologic success in HIV-1-infected children treated with lopinavir/ritonavir.Semantic proximity Read ↗

Different kinetics of immunologic recovery using nelfinavir or lopinavir/ritonavir-based regimens in children with perinatal HIV-1 infection.Semantic proximity Read ↗

Virologic and immunologic effectiveness of darunavir-based salvage therapy in HIV-1-infected adults in a Brazilian clinical practice setting: results of a multicenter and retrospective cohort study.Semantic proximity Read ↗

Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa.Semantic proximity Read ↗

Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children.Semantic proximity Read ↗

Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected children.Semantic proximity Read ↗

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.Semantic proximity Read ↗

Lamivudine monotherapy in children and adolescents: The devil is in the detail.Semantic proximity Read ↗

Immunological recovery despite virological failure is independent of human immunodeficiency virus-type 1 resistant mutants in children receiving highly active antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.